A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom
- 15 July 1991
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 277 (2) , 351-357
Abstract
The interaction of fibrinogen with its receptors on platelet surfaces leads to platelet aggregation. A snake-venom peptide, trigramin, has previously been demonstrated to inhibit platelet aggregation by acting as a fibrinogen-receptor antagonist. By means of gel filtration, ionic-exchange chromatography and reverse-phase h.p.l.c., a potent platelet-aggregation inhibitor, triflavin, has now been purified from the venom of Trimeresurus flavoviridis. The purified triflavin is a single-chain polypeptide, consisting of about 71 amino acid residues with a molecular mass of 7600 Da, and its N-terminal sequence is Gly-Glu-Glu-Cys-Asp. Triflavin dose-dependently inhibited human platelet aggregation stimulated by ADP, adrenaline, collagen, thrombin or prostaglandin endoperoxide analogue U46619 in preparations of platelet-rich plasma, platelet suspension and whole blood. Its IC50 ranged from 38 to 84 nM, depending on the aggregation inducer used and the platelet preparation. However, triflavin apparently did not affect the platelet shape change and ATP-release reactions caused by these agonists. Triflavin inhibited fibrinogen-induced aggregation of human elastase-treated platelets in a dose-dependent manner, indicating that it directly interferes with the binding of fibrinogen to its receptors on platelet membranes exposed by elastase treatment. Additionally, triflavin dose-dependently blocked 125I-labelled fibrinogen binding to ADP-activated platelets. In conclusion, triflavin inhibits platelet aggregation through the blockade of fibrinogen binding to fibrinogen receptors on platelet membranes.Keywords
This publication has 27 references indexed in Scilit:
- Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase.Journal of Clinical Investigation, 1986
- Platelet aggregation inhibitors from Agkistrodon acutus snake venomToxicon, 1986
- Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venomBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Inhibition of platelet aggregation by 5′-nucleotidase purified from Trimeresurus gramineus snake venomToxicon, 1983
- A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.Journal of Clinical Investigation, 1981
- Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated plateletsNature, 1980
- Exposure of platelet fibrinogen receptors by ADP and epinephrine.Journal of Clinical Investigation, 1979
- Inhibition of platelet secretion by an antagonist of intracellular calciumBiochemical and Biophysical Research Communications, 1976
- Correlations between the enzymatic activities and the factors active on blood coagulation and platelet aggregation from the venom of Vipera aspisBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970